IP Library Patent Application 16289853
Patent Application
App. No. 16/289,853

TABLETED CANNABINOID CHEWING GUM WITH IMPROVED RELEASE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/289,853
Abstract

The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein the chewing gum composition comprises one or more cannabinoids, and wherein the release rate of the one or more cannabinoids is more than 20% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

Claims (35)

1 - 97 . (canceled)

98 . A tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles,

wherein the chewing gum composition comprises one or more cannabinoids, and

wherein the release rate of the one or more cannabinoids is more than 20% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

99 . The tableted chewing gum composition according to claim 98 , wherein the release rate of the one or more cannabinoids is more than 30% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

100 . The tableted chewing gum composition according to claim 98 , wherein the release rate of the one or more cannabinoids is at least 40% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

101 . The tableted chewing gum composition according to claim 98 , wherein the release rate of the one or more cannabinoids is more than 20 and less than 75% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

102 . The tableted chewing gum composition according to claim 98 , wherein the release rate of the one or more cannabinoids is more than 20 and less than 60% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.

103 . The tableted chewing gum composition according to claim 98 , wherein the gum base comprising one or more natural resins in an amount of 10-40% by weight of the gum base.

104 . The tableted chewing gum composition according to claim 98 , wherein the gum base comprising one or more polyvinyl acetate elastomer plasticizers in an amount of 8-50% by weight of the gum base.

105 . The tableted chewing gum composition according to claim 98 , wherein the plurality of particles including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients.

106 . The tableted chewing gum composition according to claim 105 , wherein the first population of particles is present in an amount of at least 15% by weight of the tableted chewing gum composition.

107 . The tableted chewing gum composition according to claim 105 , wherein the second population of particles is present in an amount of at least 40% by weight of the tableted chewing gum composition.

108 . The tableted chewing gum composition according to claim 105 , wherein the content of water-insoluble gum base of the first population of particles is more than 90% by weight of the first population of particles.

109 . The tableted chewing gum composition according to claim 105 , wherein the content of water-soluble chewing gum ingredients of the second population of particles is more than 90% by weight of the second population of particles, the second population of particles being free of water-insoluble gum base.

110 . The tableted chewing gum composition according to claim 105 , wherein the one or more cannabinoids are present in the second population of particles comprising water-soluble chewing gum ingredients.

111 . The tableted chewing gum composition according to claim 105 , wherein the first population of particles and the second population of particles are substantially homogeneously distributed in a first layer of the tableted chewing gum composition.

112 . The tableted chewing gum composition according to claim 98 , wherein the water-insoluble gum base is partly located in a first layer of the chewing gum composition and the water-soluble chewing gum ingredients are partly located in a second layer of the chewing gum composition together with the one or more cannabinoids.

113 . The tableted chewing gum composition according to claim 98 , wherein the tableted chewing gum composition consists of two layers where a first layer is cohered to and adjacent to a second layer.

114 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids are part of the water-soluble chewing gum ingredients.

115 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids are located in a second layer of the chewing gum composition.

116 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids are both comprised in a first layer of the chewing gum composition and in a second layer of the chewing gum composition.

117 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids are present in an amount of 0.1 to 200 mg.

118 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids comprise cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), salts and derivatives thereof.

119 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids comprise tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), salts and derivatives thereof.

120 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids are present in a pre-mixture with one or more sugar alcohols or one or more sugars.

121 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids form part of a complex with cyclodextrin.

122 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids comprise at least one phytocannabinoid that forms part of an extract.

123 . The tableted chewing gum composition according to claim 98 , wherein the chewing gum further comprising terpenes, such as at least one terpene that forms part of an extract.

124 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids comprise at least one isolated cannabinoid.

125 . The tableted chewing gum composition according to claim 98 , wherein the one or more cannabinoids comprise at least one water-soluble cannabinoid.

126 . The tableted chewing gum composition according to claim 98 , wherein the chewing gum comprises one or more solubilizers.

127 . The tableted chewing gum composition according to claim 98 , wherein the chewing gum comprises a self-emulsifying agent.

128 . An intermediate chewing gum product for oral administration of cannabinoids, the product comprising the chewing gum composition according to claim 98 .

129 . A method of alleviating or treating a medical condition comprising administering a chewing gum composition according to claim 98 .

Assignments (3)
CHANGE OF NAME Recorded Sep 18, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053816/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2019
From: BRUUN, HEIDI ZIEGLER; BOESEN, DORTHE SCHACKINGER; ERIKSEN, ANE
To: FERTIN PHARMA A/S
Reel/Frame 049243/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2019
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 049243/0318 →